P636: A FIRST‐IN‐HUMAN PHASE 1 STUDY OF ORAL LOXO‐338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES

Kwiatek, Michal ; Subramanian Guru Murthy, Guru ; Hoffmann, Marc ; Roeker, Lindsey ; Tessoulin, Benoit ; Danilov, Alexey ; Alencar, Alvaro J. ; Shah, Nirav N. ; Ghesquieres, Herve ; Le Gouill, Steven ; Jurczak, Wojciech ; R. Mato, Anthony ; Patel, Vishalkumar ; Guo‐Avrutin, Yingying ; Pauff, James M. ; Kazmierczak, Maciej

HemaSphere, 2023-08, Vol.7 (S3), p.e216785f-n/a [Periódico revisado por pares]

Philadelphia, PA: Lippincott Williams & Wilkins

Texto completo disponível